Journal of Cancer Therapy

Vol.8 No.9(2017), Paper ID 79016, 11 pages

DOI:10.4236/jct.2017.89072

 

Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study

 

Yuki Morishita, Hiroaki Tanioka, Motoi Asano, Kotomi Tokuyama, Hiroko Okamoto, Tomohisa Okamoto, Takako Oda, Masatoshi Ohta, Masayuki Fukuzawa

 

Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan
Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan
Department of Pharmacy, Okayama Rosai Hospital, Okayama, Japan

 

Copyright © 2017 Yuki Morishita, Hiroaki Tanioka, Motoi Asano, Kotomi Tokuyama, Hiroko Okamoto, Tomohisa Okamoto, Takako Oda, Masatoshi Ohta, Masayuki Fukuzawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Morishita, Y. , Tanioka, H. , Asano, M. , Tokuyama, K. , Okamoto, H. , Okamoto, T. , Oda, T. , Ohta, M. and Fukuzawa, M. (2017) Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study. Journal of Cancer Therapy, 8, 827-837. doi: 10.4236/jct.2017.89072.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.